Taro Pharmaceutical Industries Ltd (NYSE:TARO)

101.51
Delayed Data
As of 4:02pm ET
 +0.01 / +0.01%
Today’s Change
93.01
Today|||52-Week Range
128.46
-3.06%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Taro Pharmaceutical Industries Ltd have a median target of 124.00, with a high estimate of 124.00 and a low estimate of 124.00. The median estimate represents a +22.16% increase from the last price of 101.51.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Taro Pharmaceutical Industries Ltd. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
--
Sales
-$32.8B
Reporting Date
May 24

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
 
 
 
 
 
 
Growthannually -52.26%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually -23.44%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.